Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssensys Regulatory News (ESYS)

Share Price Information for Essensys (ESYS)

Share Price is delayed by 15 minutes
Get Live Data
16.75    0.00 (0.00%)
Bid:
16.00
Ask:
17.50
Spread: 1.50 (9.375%)
Market Cap: £11.07m
ESYS Live PriceLast checked at - London Stock Exchange

Intraday Essensys Share Chart

Board Changes

24 Jun 2025 07:00

RNS Number : 0639O
essensys PLC
24 June 2025
 

24 June 2025

essensys plc

("essensys" or "Group")

Board Changes

essensys plc (AIM:ESYS), the leading global provider of software and technology to the flexible workspace industry, is pleased to announce the appointment of Sian Herbert as Independent Non-Executive Director and Chair of the Audit Committee on 1 July 2025. Sian will succeed Charles Butler, who is stepping down as member of the Board and Chair of the Audit Committee at the end of June to pursue other interests.

Sian has an extensive career in the City, spanning 35 years' experience within both the financial services and technology sectors, specifically within audit, accounting, risk, regulation and governance. This experience positions Sian to offer invaluable insight and significant strength to the essensys Board.

Sian spent a successful 25 years at PriceWaterhouseCoopers LLP ("PwC"), with 15 years as Partner. As partner, Sian developed in depth expertise in financial services, e-money and payment services, advising on risk, regulatory change and the increasing impact of technology on the sector. Over her extensive career, Sian has held a variety of leadership and senior board level positions and is a recognised expert at providing strategic advice and guidance to companies within the financial service sector. Since July 2020, Sian has held Independent Non-Executive Director and Chair of Audit and Risk Committee roles at Mitsubishi HC Capital UK PLC and AIM quoted Equals Group plc, as well as Audit Committee Chair for HBL Bank UK Limited.

Outside of these leadership positions, Sian is a member of the Institute of Chartered Accountants in England and Wales, as well as a Member of the Hong Kong Society of Accountants.

essensys' Chairman Jon Lee said: "We are delighted to welcome Sian Herbert to the essensys Board. Her impressive track record of providing insight and in-depth knowledge to companies will prove invaluable in driving forward our strategic goals and initiatives for essensys as we enter our next chapter of growth.

I would also like to take this opportunity to thank Charles Butler, who has been with us since our IPO in 2019, for his energy, guidance and support the last six years as both a Non-Executive Director and Chair of the Audit Committee. I wish him all the best in his future endeavours."

Additional information in respect of the AIM Rules

The following information relates to the appointment of Sian Anne Herbert, aged 59, who is currently, or has within the past five years been, a director or partner of the following companies:

Current Directorships and/or Partnerships

Previous Directorships and/or Partnerships (within the last five years)

Mitsubishi HC Capital UK PLC

Grange Road (Woking) Residents Management Company Ltd

HBL Bank UK Limited

Equals Group plc

PriceWaterhouseCoopers LLP

As at the date of this announcement, Sian Herbert does not hold any ordinary shares in essensys plc.

Save as set out above there are no further disclosures pursuant to Rule 17 or Schedule 2(g) of the AIM Rules for Companies in respect of the appointment of Sian Herbert.

-Ends-

 

For further information, please contact:

essensys plc 

+44 (0)20 3102 5252

James Lowery, Chief Executive Officer 

Greg Price, Chief Financial Officer

 

Canaccord Genuity Limited (Nominated Adviser and Broker) 

+44 (0)20 7523 8000 

Simon Bridges / Harry Gooden / Andrew Potts

 

Gracechurch Group 

Heather Armstrong / Alexis Gore / Rebecca Scott

+44 (0) 20 4582 3500

essensys@gracechurchpr.com

 

About essensys plc 

Founded in 2006 and listed on the London Stock Exchange AIM Market, essensys is a leading global provider of software and technology to the commercial real estate industry.

Partnering with many of the world's leading landlords and flexible workspace operators, essensys delivers innovative digital experience (DX) solutions that drive occupancy, maximise yield and reduce operating costs. Its flagship products, essensys Platform and elumo, solve the complex challenges of managing physical and digital access in dynamic multi-tenant environments, while delivering deep space utilisation insights and transformative digital experiences.

With a focus on Access, Intelligence & Experience, essensys' products enable real estate leaders to unlock the full potential of their portfolios in today's flexible, hybrid world while ensuring they stay ahead in an era of dynamic workplace evolution.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABIGDLBUDDGUX
Date   Source Headline
3rd Aug 20217:00 amRNSAppointment of CEO Asia Pacific
29th Jul 20211:35 pmRNSHolding(s) in Company
28th Jul 20216:15 pmRNSHolding(s) in Company
28th Jul 20216:13 pmRNSHolding(s) in Company
28th Jul 20216:12 pmRNSHolding(s) in Company
27th Jul 20218:50 amRNSDirector/PDMR Shareholding
26th Jul 202110:57 amRNSResults of General Meeting and Open Offer
9th Jul 20214:44 pmRNSOpen Offer Launch, Posting of Circular, GM Notice
9th Jul 20217:00 amRNSResult of Placing
8th Jul 20214:35 pmRNSProposed Fundraising
4th May 202111:44 amRNSHolding(s) in Company
21st Apr 202110:07 amRNSHolding(s) in Company
8th Apr 20217:00 amRNSDirector/PDMR Dealing
23rd Mar 20217:00 amRNSHalf-year Report
16th Mar 20212:00 pmRNSFlex Services Platform launch
10th Mar 202112:37 pmRNSNotice of Investor Meet Company Presentation
10th Mar 20217:00 amRNSNotice of Results
18th Feb 20217:00 amRNSessensys Trading Update - 18.02.2021
16th Feb 20218:28 amRNSHolding(s) in Company
9th Feb 20217:00 amRNSAppointment of Joint Corporate Broker
24th Dec 20209:46 amRNSDirector/PDMR Shareholding
24th Nov 20205:29 pmRNSResult of AGM
4th Nov 20207:00 amRNSAppointment of CEO North America and PDMR Dealing
30th Oct 20205:27 pmRNSPosting of Annual Report and Accounts & AGM Notice
13th Oct 20203:35 pmRNSNotice of Investor Meet Company Presentation
13th Oct 20207:00 amRNSessensys plc - Full Year Results
7th Oct 20207:00 amRNSNotice of Results
24th Aug 20203:09 pmRNSHolding(s) in Company
24th Aug 202011:41 amRNSReplacement: Holding(s) in Company
24th Aug 202010:44 amRNSHolding(s) in Company
18th Aug 20207:00 amRNSTrading Statement
9th Apr 202012:17 pmRNSResult of Placing
9th Apr 20207:01 amRNSProposed placing to raise approximately £7 million
9th Apr 20207:00 amRNSHalf year results
24th Mar 20207:01 amRNSessensys - Market and trading update
18th Feb 20207:00 amRNSTrading Statement
30th Jan 20202:26 pmRNSBoard Appointments and Grant of Options
28th Nov 20191:31 pmRNSResult of Annual General Meeting
1st Nov 20194:30 pmRNSNotice of AGM
22nd Oct 20197:00 amRNSFull Year Results
8th Oct 20197:00 amRNSNotice of Full Year Results
13th Aug 20197:00 amRNSessensys Pre-Close Trading Update
3rd Jun 201912:32 pmRNSHolding(s) in Company
30th May 20192:36 pmRNSHolding(s) in Company
29th May 20192:05 pmRNSSecond Price Monitoring Extn
29th May 20192:00 pmRNSPrice Monitoring Extension
29th May 20197:00 amRNSAdmission to trading on AIM, First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.